Holen Sie sich die Stockscreener-App
188.12
1.53%
-2.19
Schlusskurs vom Vortag:
$190.31
Offen:
$191.38
24-Stunden-Volumen:
485.97K
Relative Volume:
0.42
Marktkapitalisierung:
$26.66B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$-208.16M
KGV:
-122.43
EPS:
-1.5366
Netto-Cashflow:
$76.11M
1W Leistung:
-5.42%
1M Leistung:
-9.13%
6M Leistung:
+11.20%
1J Leistung:
+31.49%
1-Tages-Spanne:
$187.15
$192.36
1-Wochen-Bereich:
$186.07
$207.08
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
188.12 | 26.97B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
469.64 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.47 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
570.68 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.67 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
285.13 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Natera launches whole genome sequencing test for rare diseases - Investing.com South Africa
GeneDx stock falls as Natera launches competing rare disease test - Investing.com UK
Natera announces commercial launch of Zenith genomics - TipRanks
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - BioSpace
Natera, Inc. $NTRA Shares Sold by Swiss National Bank - MarketBeat
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - PR Newswire
Natera, Inc. $NTRA Shares Bought by Franklin Resources Inc. - MarketBeat
Capital Fund Management S.A. Buys 41,307 Shares of Natera, Inc. $NTRA - MarketBeat
Natera director Sheena Jonathan sells $25924 in stock - Investing.com
Natera president Fesko sells $144k in shares - Investing.com
Natera director Sheena Jonathan sells $25924 in stock By Investing.com - Investing.com India
Natera: Daniel Rabinowitz sells $356k in shares By Investing.com - Investing.com India
Natera president Fesko sells $144k in shares By Investing.com - Investing.com India
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 5,623 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 707 Shares of Stock - MarketBeat
Michael Burkes Brophy Sells 785 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CFO Brophy sells $160k in NTRA stock - Investing.com
Natera CEO Steven Chapman sells $1.15 million in shares - Investing.com
Natera Is Quietly Raising Signatera Pricing Power — Could This Hidden Catalyst Supercharge Revenue Growth? - Smartkarma
Natera (NASDAQ:NTRA) Insider Sells $186,778.95 in Stock - MarketBeat
The Bull Case For Natera (NTRA) Could Change Following 2026 Guidance And New Signatera Bladder Data - simplywall.st
Natera at Leerink Global Healthcare Conference: Strategic Growth and Investment By Investing.com - Investing.com
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
3 Healthcare Stocks to Target This Week - Finviz
Evercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating - MSN
Rhenman & Partners Asset Management AB Reduces Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Neuberger Berman Group LLC - MarketBeat
Dynamic Technology Lab Private Ltd Acquires New Position in Natera, Inc. $NTRA - MarketBeat
Quantbot Technologies LP Buys Shares of 6,638 Natera, Inc. $NTRA - MarketBeat
Wall Street Zen Upgrades Natera (NASDAQ:NTRA) to "Buy" - MarketBeat
How Natera Inc. stock reacts to inflationary pressuresGlobal Markets & Weekly High Conviction Ideas - Naître et grandir
Bear Alert: Can Natera Inc outperform in the next rally2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn
Natera Inc. Earnings Call Signals Profitable Growth - TipRanks
Assessing Natera (NTRA) Valuation After Earnings Beat And Raised 2026 Guidance - simplywall.st
Fed Meeting: Can Bone Biologics Corporation Equity Warrant generate free cash flowQuarterly Trade Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Victory Capital Management Inc. Sells 165,275 Shares of Natera, Inc. $NTRA - MarketBeat
Pura Vida Investments LLC Has $402,000 Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by GW&K Investment Management LLC - MarketBeat
ARK Investment Management LLC Decreases Stake in Natera, Inc. $NTRA - MarketBeat
Amova Asset Management Americas Inc. Has $101.13 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera at Raymond James Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria
Natera at Raymond James Conference: Strategic Growth and Innovation - Investing.com
How Natera’s 2025 Results and SINERGY Trial Data May Shape Natera (NTRA) Investors’ Expectations - simplywall.st
Natera Shares Gain After Analyst Reiterates Buy Rating on Q4 BeatNews and Statistics - IndexBox
Signatera Oncology Test Drives Natera’s (NTRA) Growth - Insider Monkey
Signatera Oncology Test Drives Natera's (NTRA) Growth - Bitget
Picton Mahoney Asset Management Sells 17,139 Shares of Natera, Inc. $NTRA - MarketBeat
Insider Sell: Steven Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 3,950 Shares - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Jonathan Sheena of Natera (NTRA) logs stock sales and new 2,103 RSU grant - Stock Titan
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Mar 10 '26 |
Sale |
204.13 |
785 |
160,244 |
63,354 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Mar 10 '26 |
Sale |
204.13 |
5,623 |
1,147,838 |
156,607 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Mar 10 '26 |
Sale |
204.13 |
1,745 |
356,212 |
233,285 |
| Sheena Jonathan | CO-FOUNDER |
Mar 10 '26 |
Sale |
204.13 |
127 |
25,925 |
262,325 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Mar 10 '26 |
Sale |
204.13 |
707 |
144,322 |
189,199 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Mar 10 '26 |
Sale |
204.13 |
915 |
186,781 |
150,882 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Mar 06 '26 |
Option Exercise |
19.68 |
5,598 |
110,169 |
241,683 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Mar 06 '26 |
Sale |
196.08 |
8,398 |
1,646,696 |
233,285 |
1.70%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):